| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Co-chief Executive Officer
1 company
Cohen Joshua B is a Co-chief Executive Officer at AMLX. Recent filings cover 0 purchases and 20 sales. Those positions are worth an estimated $119.8M at current prices.
Our model assigns Cohen Joshua B a middling insider score of 60/100, based on 11 past trades. Over a 12-month horizon, 44.4% of those trades were profitable, with an average 12-month return of -21.8%.
Cohen Joshua B's largest disclosed position is in AMLX as Co-chief Executive Officer, worth about $119.8M. The recent filings there lean toward selling, a net 431,001 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 30,464 | $32.19 | $980,503.90 | -0.8% | - | - | |
| Mar 2, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 29,282 | $14.48 | $424,120.49 | -0.9% | -8.0% | - | |
| Feb 2, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 15,500 | $14.68 | $227,592.70 | -0.5% | +12.2% | - | |
| Jan 16, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sale+OE | 138,167 | $13.59 | $1,878,093.81 | -3.9% | +24.0% | - | |
| Jan 6, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 7,715 | $11.09 | $85,596.38 | -0.2% | +39.0% | - | |
| Sep 30, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 29,933 | $14.35 | $429,468.84 | -0.9% | -10.3% | +114.1% | |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 21,490 | $3.47 | $74,482.19 | -0.6% | +81.1% | +292.7% | |
| Mar 3, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 4,595 | $3.17 | $14,549.15 | -0.1% | +70.0% | +370.3% | |
| Feb 3, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 11,851 | $3.47 | $41,107.56 | -0.4% | +50.6% | +323.7% | |
| Jan 6, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 7,471 | $4.05 | $30,232.15 | -0.2% | -11.7% | +190.3% |